ABO blood types have been associated with the development of coronary heart disease, stroke, and venous thromboembolism [1–3], in part by regulating levels of von Willebrand factor (VWF) and coagulation factor VIII (FVIII) in the circulation [4;5]. This evidence concerns the gene F8 and coronary artery disorder.